6.95 Percent of U.S. Adults Have Been Present at Scene of Mass Shooting
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, March 10, 2025 -- Overall, 6.95 percent of U.S. adults report being present at the scene of a mass shooting, and 2.18 percent sustained physical injuries during these incidences, according to a study published online March 7 in JAMA Network Open.
David C. Pyrooz, Ph.D., from the University of Colorado Boulder, and colleagues estimated the prevalence of direct exposure to mass shootings among U.S. adults using a survey administered to 10,000 respondents designed to be representative of U.S. adults.
Of the respondents, 51.34 percent were female and 3.04, 12.46, 16.04, 62.78, and 5.67 percent were Asian, Black, Hispanic, White, and other race or ethnicity, respectively. The researchers found that 6.95 percent of respondents were present at the scene of a mass shooting; 2.18 percent sustained physical injuries during such incidences, including being shot or trampled. More than half (54.89 percent) of the mass shootings to which respondents were exposed occurred in 2015 or more recently; more than three-quarters (76.15 percent) occurred in respondents' local communities. The likelihood of reporting exposure was higher for younger individuals (e.g., adjusted odds ratio, 0.12 for Baby Boomer and Silent generation versus Generation Z) and for males versus females (adjusted odds ratio, 1.55). Compared with White respondents, Black and Asian respondents reported higher and lower rates of being present at mass shootings, respectively (adjusted odds ratios, 1.87 and 0.36, respectively).
"Future research should further investigate how direct exposure to these incidents shapes individuals' health and well-being, with particular attention to the broader community and the potential for systemic interventions that promote safety and resilience," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-11 12:00
Read more

- RFK Jr. Confirmed as Health Secretary in Near Party-Line Vote
- Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis
- GLP-1 Drugs Improve Outlook For Kidney Transplants
- Recent Decade Saw Rise in Number of Adults With Severe Obesity
- Americans Borrowed $74 Million in 2024 to Cover Medical Costs
- Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions